The scientific award, inaugurated in 2011 by the EMCDDA and its Scientific Committee, celebrates scientific writing and distinguishes high-quality research in the field of illicit drugs. Scientific papers judged to enhance understanding of the European drugs problem are acknowledged yearly in an award ceremony.
This year's award will take place on 10-11 November, in the margins of the 45th meeting of the EMCDDA Scientific Committee.
The award showcases innovative research in the drugs field. Each year, the EMCDDA asks its partners to nominate papers focusing on illicit drugs or new psychoactive substances. The articles will have been published in the previous year in a peer-reviewed scientific journal, with the primary author being of European nationality or based in a European country.
Each nominated paper should be classified according to the following research fields: Basic biological, neurobiological and behavioural research (including aetiological and addictive behaviour research); Population based research and clinical epidemiology (including site surveys, ethnographic studies and acute toxicity studies); Demand reduction (including prevention, treatment, harm reduction, reintegration and clinical treatment research); Supply, supply reduction and crime; Drug policy (including laws, economic issues and strategies); Other topics.
A total of 53 eligible articles were nominated for the 2016 edition of the EMCDDA scientific award. The Scientific Committee established the shortlists for each category and adopted the composition of the jury. The articles on the shortlist will now be rated by the jury and the award ceremony will take place in the margins of the 45th meeting of the Scientific Committee (10-11 November).
The scientific award was inaugurated in 2011 to showcase innovative research in drugs field.